Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 March 2025 | Story Tshepo Tsotetsi | Photo Supplied
faculty of the Humanities graduation
Congratulations to our UFS leaders of the future!

As the leaves turn and autumn settles over the Free State, a new season of celebration is upon us. Gowns are being dusted off, caps are ready to be tossed, and excitement is building as the University of the Free State (UFS) prepares to honour the Class of 2024. From 4 to 5 April 2025, the Qwaqwa Campus will host its graduation ceremonies, followed by the Bloemfontein Campus from 8 to 12 April 2025.

This year, a total of 7 994 students will walk the stage, marking a significant moment in their academic journeys. The university will host 20 graduation ceremonies across its Qwaqwa and Bloemfontein Campuses, celebrating the accomplishments of graduates across all faculties. In addition to awarding degrees and diplomas, the UFS will also confer three honorary doctorates, recognising exceptional contributions in various fields.

Graduation is more than just a ceremony; it is a defining moment. It marks the end of years of late-night studying, countless assignments, and moments of self-doubt. But more importantly, it signals the beginning of something new. Armed with their degrees, the UFS graduates will soon step into the world beyond university, ready to make their mark.

At the UFS, excellence is more than a value – it is a standard. Every graduate walking across the stage embodies the university’s commitment to producing individuals who are not only knowledgeable but also adaptable, resilient, and prepared for the ever-changing demands of the world. This is at the heart of Vision 130, UFS’s roadmap to 2034, which focuses on shaping graduates who will contribute meaningfully to both local and global communities.

For the Class of 2024, the journey has been long, challenging, and rewarding. Now, as they prepare to walk the stage, one thing is certain: the future is theirs to shape.

 

Click to view document WATCH: 2025 Graduation Livestream 

 

Click to view documentClick here to see the full schedule for the 2025 April graduations.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept